AbbVie (ABBV) reports earnings before the market opens, with historically low volatility and an expected move of 4%. The stock’s pre-earnings momentum suggests a bullish continuation, reinforced by rising short interest. While short interest is typically bearish, its correlation with price gains indicates traders are betting on continued strength.

ABBV is reporting before the market open, and it is generally a less volatile stock, with an average move of 4% both historically and as implied by the options market.

This indicates the market is expecting a relatively muted reaction.

The stock tends to show momentum after earnings, continuing the trend it had leading up to the report. Since ABBV is up before earnings, this suggests the market is anticipating a positive earnings result or continuation of the bullish sentiment.

The short interest has been rising along with the stock price recently. Typically, a rise in short interest is seen as a bearish sign, but in this case, it’s correlating with the momentum seen in the stock price, reinforcing a bullish outlook.

Longer term, the short interest is still relatively high, but the stock price has remained steady.

The positive correlation between short interest and stock price means that shorts tend to build up as the stock moves higher, and then they cover when the stock moves lower, playing into the momentum of the stock.

ABBV has a small short position and no analysts. with sell recommendations.

AbbVie (ABBV) remains a low-volatility stock, but its pre-earnings momentum and short positioning suggest potential upside. With no analysts issuing sell ratings and shorts covering on price declines, the market setup supports a bullish continuation. While implied volatility is stable, earnings momentum could drive a stronger-than-expected reaction.

Want to know more?

Access this data in real time using S3’s BLACK APP or Contact us to get started.